Ex-Inotek Exec to Lead Flex Pharma as Westphal Steps Down

Xconomy Boston — 

Christoph Westphal has stepped down as the CEO of Flex Pharma (NASDAQ: FLKS). William McVicar, a former Inotek Pharmaceuticals executive and currently Flex’s president of R&D, will serve as Flex’s interim CEO. Westphal, who helped form the company, will remain chairman.